Synergistic Benefits: Exploring the Anti-Virulence Effects of Metformin/Vildagliptin Antidiabetic Combination against Pseudomonas aeruginosa via Controlling Quorum Sensing Systems

The repurposing of drugs is one of the most competent strategies for discovering new antimicrobial agents. Vildagliptin is a dipeptidyl peptidase-4 inhibitor (DPI-4) that is used effectively in combination with metformin to control blood glucose levels in diabetic patients. This study was designed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Khayat, Maan T., Abbas, Hisham A., Ibrahim, Tarek S., Elbaramawi, Samar S., Khayyat, Ahdab N., Alharbi, Majed, Hegazy, Wael A. H., Yehia, Fatma Al-zahraa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216381/
https://www.ncbi.nlm.nih.gov/pubmed/37239113
http://dx.doi.org/10.3390/biomedicines11051442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216381/
https://www.ncbi.nlm.nih.gov/pubmed/37239113
http://dx.doi.org/10.3390/biomedicines11051442

Ejemplares similares